Kennedy Capital Management, Inc. Aprea Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$0.62 - $1.94 $207,573 - $649,504	-334,796 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.59 - $3.16 $3,075 - $6,111	-1,934 Reduced 0.57%	334,796 $623,000
Q4 2021 Feb 14, 2022	SELL	$2.87 - $5.58 $16,519 - $32,118	-5,756 Reduced 1.68%	336,730 $966,000
Q3 2021 Nov 15, 2021	SELL	$3.43 - $5.63 $39,239 - $64,407	-11,440 Reduced 3.23%	342,486 $1.75 Million
Q2 2021 Aug 16, 2021	BUY	$4.05 - $5.5 $1.22 Million - $1.66 Million	301,511 Added 575.24%	353,926 $1.73 Million
Q1 2021 May 14, 2021	BUY	$4.73 - $8.15 $247,922 - $427,182	52,415 New	52,415 $267,000
Q4 2020 Feb 12, 2021	SELL	$4.92 - $30.67 $921,786 - $5.75 Million	-187,355 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$21.66 - $38.86 $1.21 Million - $2.17 Million	55,941 Added 42.57%	187,355 $4.51 Million
Q2 2020 Aug 14, 2020	BUY	$25.47 - $39.69 $106,566 - $166,062	4,184 Added 3.29%	131,414 $5.1 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $45.3 $1.08 Million - $1.55 Million	34,241 Added 36.82%	127,230 $4.42 Million
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $1.76 Million - $4.61 Million	92,989 New	92,989 $4.27 Million

Others Institutions Holding APRE

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.